Capillus® is a non-surgical hair restoration option for both men and women who suffer with thinning, shedding, or balding hair. Derived from the Latin word meaning total of hair on the scalp, the Capillus® shines where other LLLT devices fall short. With 272 low level laser diodes and a compact under-the-cap construction, the FDA-Cleared Capillus272 is designed to reawaken dormant hair follicles and spur newer, fuller hair growth with comprehensive LLLT exposure to the entire scalp.

Overwhelmingly, physicians are recommending low level laser therapy to augment the treatment of hair loss. LLLT can be used in conjunction with today’s leading hair loss treatments, including topical solutions, prescription medications, and even hair transplant. In fact, hair restoration surgeons recommend the use of LLLT devices, like Capillus®, before and after hair transplant to improve hair health, reduce inflammation, and improve patient results.

The Capillus® is indicated to promote hair growth in females with androgenetic alopecia who have Ludwig-Savin Classifications of I- II and Fitzpatrick Classification of Skin Phototypes I to IV.

The FDA-Cleared Capillus272 uses safe, low level lasers designed to energize hair follicles and spur new, natural hair growth. Under the guidance of a hair restoration professional, Capillus® may be used as a stand-alone treatment for hair loss or in conjunction with topical foams, prescription medications, and hair transplant surgeries. The device and treatment protocol is cleared by the FDA to promote hair growth in males and females with androgenetic alopecia (AGA) who have Ludwig-Savin Classifications of I-II or Norwood Hamilton classifications of IIa-V and Fitzpatrick Classification of Skin Phototypes I to IV.